BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3251268)

  • 1. [Difference in mechanism of action of sulpiride and haloperidol on dopamine brain turnover].
    Imazu Y; Kobayashi K; Shomori T
    Seishin Shinkeigaku Zasshi; 1988; 90(10):845-52. PubMed ID: 3251268
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative study of sulpiride and haloperidol on dopamine turnover in the rat brain.
    Imazu Y; Kobayashi K; Shohmori T
    Neurochem Res; 1989 May; 14(5):459-64. PubMed ID: 2747836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic treatment with 1-sulpiride and haloperidol on central dopamine turnover evaluated in dopamine cell body and nerve terminal-rich areas.
    Agnati LF; Andersson K; Fuxe K; Benfenati F; Cortelli P; D'Alessandro R; Ogren SO
    Adv Biochem Psychopharmacol; 1980; 24():75-80. PubMed ID: 7405679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of long-term dosing with tiapride on brain dopamine receptors and metabolism in rats. Comparative study with sulpiride and haloperidol.
    Satoh H; Kuwaki T; Shirakawa K; Kohjimoto Y; Ono T; Shibayama F; Nomura Y
    Jpn J Pharmacol; 1987 Aug; 44(4):393-403. PubMed ID: 3682405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the action of (+/-)sulpiride on dopamine receptors in the rat brain in vivo.
    Hasan F; Leonard BE
    Neuropharmacology; 1981 Dec; 20(12B):1327-30. PubMed ID: 7198724
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of carbidine, sulpiride and haloperidol on levels of monoamines and their metabolites in the brain structures of rats].
    Miroshnichenko II; Kudrin VS; Raevskiĭ KS
    Farmakol Toksikol; 1988; 51(2):26-9. PubMed ID: 2897932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related changes in rat brain dopaminergic receptors.
    Petkov VV; Petkov VD; Grahovska T; Konstantinova E
    Acta Physiol Pharmacol Bulg; 1984; 10(4):16-27. PubMed ID: 6535368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of long-term treatment with haloperidol and sulpiride on different types of dopaminergic receptors.
    Trabucchi M; Memo M; Battaini F; Reggiani A; Spano PF
    Adv Biochem Psychopharmacol; 1980; 24():275-81. PubMed ID: 7405667
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic haloperidol does not increase specific dopamine receptor binding in rat frontal cortex.
    Meller E; Bohmaker K; Rosengarten H; Friedhoff AJ
    Res Commun Chem Pathol Pharmacol; 1982 Sep; 37(3):323-32. PubMed ID: 7178646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of multiple receptors for dopamine.
    Spano PF; Memo M; Stefanini E; Fresia P; Trabucchi M
    Adv Biochem Psychopharmacol; 1980; 21():243-51. PubMed ID: 7376971
    [No Abstract]   [Full Text] [Related]  

  • 11. [Action of haloperidol on the ultrastructure of areas of the dopaminergic system of the brain].
    Klintsova AIu; Uranova NA; Schenk H; Hasselhorst U
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(7):1028-31. PubMed ID: 3673382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of subchronic haloperidol and sulpiride on regional brain dopamine metabolism in the rat.
    Lindefors N; Sharp T; Ungerstedt U
    Eur J Pharmacol; 1986 Oct; 129(3):401-4. PubMed ID: 3780852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic drug effects on dopamine and serotonin receptors: in vitro binding and in vivo turnover studies.
    Bacopoulos NG
    J Pharmacol Exp Ther; 1981 Dec; 219(3):708-14. PubMed ID: 6170752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of serotonin and dopamine receptors in the mechanism of action of haloperidol and pirenperone].
    Maĭmets MO; Vasar EE; Nurk AM; Allikmets LKh
    Farmakol Toksikol; 1985; 48(2):15-8. PubMed ID: 3996566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitive periods for the effect of haloperidol on development of striatal dopamine receptors.
    Rosengarten H; Friedman E; Friedhoff AJ
    Birth Defects Orig Artic Ser; 1983; 19(4):511-3. PubMed ID: 6871420
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in sensitivity of release modulating dopamine autoreceptors after chronic treatment with haloperidol.
    Nowak JZ; Arbilla S; Galzin AM; Langer SZ
    J Pharmacol Exp Ther; 1983 Aug; 226(2):558-64. PubMed ID: 6875865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dopamine antagonists and their mechanism of action].
    Yamada K; Furukawa T
    Nihon Rinsho; 1984 Apr; 42(4):808-14. PubMed ID: 6148436
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopamine metabolism in the rat retina and brain after acute and repeated treatment with neuroleptics.
    Scatton B; Dedek J; Korf J
    Adv Biochem Psychopharmacol; 1978; 19():373-5. PubMed ID: 29452
    [No Abstract]   [Full Text] [Related]  

  • 19. [Problem of neuronal reception and the dopamine hypothesis of schizophrenia].
    Lideman RR; Zlobina GP; Mukhin AG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):762-9. PubMed ID: 6106337
    [No Abstract]   [Full Text] [Related]  

  • 20. Levels of insulin in the brains of rats modified by chronic administration of amphetamine, haloperidol and sulpiride.
    Manzanares J; Cantón R; Grande C; Benedí J; Zaragozá F
    Neuropharmacology; 1988 Nov; 27(11):1141-4. PubMed ID: 3060757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.